Skip to main content

Table 1 Study demographic characteristics of never users and ever users of calcium channel blocking drugs at study baseline

From: Long-term use of calcium channel blocking drugs and breast cancer risk in a prospective cohort of US and Puerto Rican women

 

Calcium channel blocker use

 

Never used (N = 46,904)

Used (N = 3853)

p valuea

Age at baseline

54.5 (48.0–61.0)

60.2 (55.0–66.0)

<0.0001

Age at menarche

12.7 (12.0–13.0)

12.4 (11.5–13.0)

<0.0001

Race

  

<0.0001

 Non-Hispanic White

39,705 (85)

2748 (71)

 

 Non-Hispanic Black

3655 (8)

797 (21)

 

 Hispanic

2311 (5)

197 (5)

 

 Other

1219 (3)

110 (3)

 

 Missing

14 (<1)

0 (<1)

 

Body mass index

  

<0.0001

 <25

18,588 (40)

786 (20)

 

 25.0–29.9

14,953 (32)

1166 (30)

 

 30.0–34.9

7839 (17)

944 (25)

 

 35.0+

5508 (12)

956 (25)

 

 Missing

16 (<1)

1 (<1)

 

Menopause status

  

<0.0001

 Pre menopause

14,254 (30)

461 (12)

 

 Post menopause

32,332 (69)

3381 (88)

 

 Missing

318 (1)

11 (<1)

 

Ever pregnant

  

<0.0001

 No

5947 (13)

407 (11)

 

 Yes

40,935 (87)

3445 (89)

 

 Missing

22 (<1)

1 (<1)

 

Ever used hormone replacement therapy

  

<0.0001

 No

26,193 (56)

1532 (40)

 

 Yes

20,561 (44)

2313 (60)

 

 Don’t know/missing

150 (<1)

8 (<1)

 

Ever diagnosed with cancerb

  

0.0009

 No

44,612 (95)

3613 (94)

 

 Yes

2241 (5)

230 (6)

 

 Don’t know/missing

51 (<1)

10 (<1)

 

Smoking status

  

<0.0001

 Never smoked

26,441 (56)

2045 (53)

 

 Past smoker

16,604 (35)

1487 (39)

 

 Current smoker

3845 (8)

318 (8)

 

 Don’t know/missing

14 (1)

3 (<1)

 
  1. Data presented as mean (interquartile range) of N (%)
  2. aCalculated using chi-square tests and Student’s t tests as appropriate
  3. bCancers other than breast cancer (excluding basal-cell carcinoma)